Abstract mRNA vaccines have emerged as highly effective strategies in the prophylaxis and
treatment of diseases, thanks largely although not totally to their extraordinary performance …

Skin cancer is a global threat to the healthcare system and is estimated to incline
tremendously in the next 20 years, if not diagnosed at an early stage. Even though it is …

In late 2020, the US Food and Drug Administration (FDA) approved a lipid-based mRNA
vaccine for the prevention of COVID-19, which has pushed this field to be more closely …

Cancer vaccines exhibit specificity, effectiveness, and safety as an alternative
immunotherapeutic strategy to struggle against malignant diseases, especially with the rapid …

Years of research exploring mRNA vaccines for cancer treatment in preclinical and clinical
trials have set the stage for the rapid development of mRNA vaccines during the COVID-19 …

Messenger RNAs (mRNAs) were previously shown to have great potential for preventive
vaccination against infectious diseases and therapeutic applications in the treatment of …

Messenger RNA (mRNA) is now in the limelight as a powerful tool for treating various
human diseases, especially malignant tumors, thanks to the remarkable clinical outcomes of …

An mRNA with unmodified nucleosides induces type I interferons (IFN-I) through the
stimulation of innate immune sensors. Whether IFN-I induced by mRNA vaccine is crucial for …

Abstract mRNA vaccines have gained popularity over the last decade as a versatile tool for
developing novel therapeutics. The recent success of coronavirus disease (COVID-19) …

Messenger RNA (mRNA) vaccines are promising platforms for cancer immunotherapy
because of their potential to encode for a variety of tumor antigens, high tolerability, and …